SUNSHINE BIOPHARMA INC (SBFM)
US8677816014 - Common Stock
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.
3 Penny Stocks Ready to Explode Into Dollar Signs by 2028
The best penny stocks to buy are those you can understand and stomach the exceptional risks of in order to profit.
Which stocks are moving on Thursday?
Thursday's session: top gainers and losers
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
SBFM Stock Earnings: Sunshine Biopharma Beats EPS, Beats Revenue for Q1 2024
SBFM stock results show that Sunshine Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
SBFM Stock Earnings: Sunshine Biopharma Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sunshine Biopharma (NASDAQ:SBFM) just reported results for the first quarter of...
3 Meme Stocks to Sell That Even Roaring Kitty Can’t Save
Looking for the best meme stocks to sell after the Roaring Kitty rally? These three struggling companies seem to be beyond hope.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Tuesday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Friday is here and we're breaking down the biggest pre-market stock movers that traders need to know about this morning!
SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q4 2023
SBFM stock results show that Sunshine Biopharma missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sunshine Biopharma (NASDAQ:SBFM) just reported results for the fourth quarter o...